Cancer Nanotechnology Plan
Path-breaking directions of nanotechnology-based chemotherapy and molecular cancer therapy
D Banerjee Abstract 2009c
Fortis Oncology - Nanomedicine Solutions
Best Practices in Cancer Nanotechnology_Perspective From NCI Nanotechnology Alliance
MSEL MEL CSTL Metrology for the “Fate” of Nanoparticles in Biosystems Michael T. Postek, Andras Vladar, Thomas LeBrun and John Dagata, MEL John Small,
NAB-paclitaxel, un innovativo meccanismo d’azione
Research in the Emory School of Medicine David Stephens Trish Haugaard Jeff Sands September 2006.
